Navigation Links
Gen-Probe Reports Strong Financial Results for Third Quarter 2007, Raises Full-Year Guidance for Earnings Per Share and Total Revenues
Date:10/30/2007

nt periodic reports. We assume no obligation and expressly disclaim any duty to update forward-looking statements to reflect events or circumstances after the date of this news release or to reflect the occurrence of subsequent events.

Contact:

Michael Watts

Sr. director, investor relations and

corporate communications

858-410-8673

Gen-Probe Incorporated

Consolidated Balance Sheets

(In thousands, except share and per share data)

September 30, December 31,

2007 2006

(Unaudited)

Assets

Current assets:

Cash and cash equivalents $66,888 $87,905

Short-term investments 328,185 202,008

Trade accounts receivable, net of allowance for

doubtful accounts of $750 and $670 at

September 30, 2007 and December 31,

2006, respectively 38,235 25,880

Accounts receivable - other 5,166 1,646

Inventories 49,186 52,056

Deferred income tax - short term 6,673 7,247

Prepaid income tax 16,229 -

Prepaid expenses 17,874 11,362

Other current assets 5,374 2,583

Total current assets 533,810 390,687

Property, plant and equipment, net 131,245 134,614

Capitalized software 16,552 18,437

Goodwill 18,621 18,621

Deferr
'/>"/>

SOURCE Gen-Probe Incorporated
Copyright©2007 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3 4 5 6 7 8 9 10 11 12 13 14

Related biology technology :

1. TomoTherapy reports 86% revenue jump, $131M net loss in Q1
2. Sonic Foundry reports GAAP loss as Q2 revenues rise
3. Fiserv reports $113.5 million in Q1 profit
4. Third Wave reports net loss of $18.9M for 2006
5. Musicnotes reports 45 percent growth in 2006
6. Sonic Foundry reports net loss, higher revenue
7. Sonic Foundry reports first cash-positive quarter
8. Merge Healthcare reports $10.8M net loss in Q3
9. Third Wave reports $5.2M third quarter loss
10. Merge Healthcare appoints new CEO, reports $215 million Q2 loss
11. Merge files financial reports by market opening

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/2/2009)...pines, Dec. 2 Spectrum Blue Steel ...ergy companies on the planet. Through the efforts ... President and Recycling Specialist Leroy Johnston...25 years, stated that Spectrum Blue Steel is light...for spectacular earnings because of the bi product...
(Date:12/2/2009)...c. 2 Nearly 600 medical...nd funders today convened to explore novel develop...at the inaugural Partnering for Cures meeting. ...f the Milken Institute, convened Partnering for C...eded to turn a scientific discovery into an access...
(Date:12/2/2009)...LE, Gabon, December 2 , -...oblem and Heritage" , Coinciding with the... the,Gabonese Republic is hosting an international...safeguarding biological resources in Africa. The,c... leaders, ministers,scientific experts, private c...
(Date:12/2/2009)...RE, Dec. 2 S*BIO Pte Ltd today ann...nhibitor, SB1518, at The American Society of Hemat...leans. ,, Data will be presented on the clinica...f SB1518 detailing its safety, tolerability and ph...ose levels ranging from 100 to 600 mg. These doses...
Breaking Biology Technology:Spectrum Blue Steel partners with Famous Chemists for Procuring Profitable Applications from Garbage Using the Biosphere MKV and Electrostatic Precipitators 2Spectrum Blue Steel partners with Famous Chemists for Procuring Profitable Applications from Garbage Using the Biosphere MKV and Electrostatic Precipitators 3Medical Research Leaders Explore Novel Strategies to Expedite the Search for Cures 2Libreville International Conference 2-3 June 2010 2S*BIO Novel Oral JAK2 Inhibitor SB1518 Demonstrates Safety and Tolerability in Phase 1 Studies for the Treatment of Myeloproliferative and Other Hematological Disorders 2S*BIO Novel Oral JAK2 Inhibitor SB1518 Demonstrates Safety and Tolerability in Phase 1 Studies for the Treatment of Myeloproliferative and Other Hematological Disorders 3S*BIO Novel Oral JAK2 Inhibitor SB1518 Demonstrates Safety and Tolerability in Phase 1 Studies for the Treatment of Myeloproliferative and Other Hematological Disorders 4S*BIO Novel Oral JAK2 Inhibitor SB1518 Demonstrates Safety and Tolerability in Phase 1 Studies for the Treatment of Myeloproliferative and Other Hematological Disorders 5
...Since the dot-com boom days are over and soaring t...s putting their money? Whats their criteria for in...start-up firm looking for investment capital, you ...me cases, former self-proclaimed savvy investors h...ally looking at any investments unless its for som...
...Researchers often encounter certain genes, chromos... difficult to clone. Lucigen,s CloneSmart technolo...the difficulties inherent to cloning, from an indi...tilizes a series of low-background vectors designe...ith conventional vectors. , ,Our collaboration wi...
...MILWAUKEE, Wis. April 30 -FirstCall/ -- Merge Tec...aq: MRGE), today announced the financial results f... the quarter ended March 31, 2003, were over $6,Mi...illion in the quarter ended March 31, 2002. In the... Million generating $0.11 diluted EPS compared to ...
Other Biology Technology:Where have all the Midwest VCs gone? 2Where have all the Midwest VCs gone? 3Molecular Cloning Systems Gets Distributor 2Merge has 87% Increase in Net Income 2Merge has 87% Increase in Net Income 3Merge has 87% Increase in Net Income 4
(Date:12/2/2009)... their first cigarette within minutes after waking...uct of nicotine when processed by the body, than t...f cigarettes smoked. , "Since cotinine levels...sults suggest that smokers who smoke immediately a...cer," said researcher Joshua E. Muscat, Ph.D., M.P...
(Date:12/2/2009)...ndhand smoke for a prolonged period of time and in...cer, even in women who never smoked cigarettes the... side-stream smoke could increase risk of breast c...lds, Ph.D., senior research scientist at the North...hile no single epidemiologic study can answer the ...
(Date:12/2/2009)...ky Mountain forest,s woodland herb population has ...nderstories recover from logging, according to Pur... in portions of the forest nearly 80 years ago, th... forest floor was similar to that of undisturbed a...r of forestry and natural resources, said that con...
Breaking Biology News(10 mins):Increased nicotine levels detected in those who light-up earlier 2Exposure to secondhand cigarette smoke over a lifetime increased breast cancer risk later in life 2Study finds logging effects vary based on a forest's history, climate 2Texas Dental Association Offers Premier Accounts Receivable Management Services from TekCollect via TDA Perks Program 56100 1Texas Dental Association Offers Premier Accounts Receivable Management Services from TekCollect via TDA Perks Program 56100 2Find Qualified Consulting Firms Quickly and Efficiently 56097 1Find Qualified Consulting Firms Quickly and Efficiently 56097 2Find Qualified Consulting Firms Quickly and Efficiently 56097 3NC State receives NSF grant to discover plant switchboards 9774 1NC State receives NSF grant to discover plant switchboards 9774 2NC State receives NSF grant to discover plant switchboards 9774 3
...e in protecting us from diseases, but how does it ...n discovered that before dendritic cells move to t...elps them to move much faster. Immature dendritic ...ter exposure to such antigens they undergo a rigor... dendritic cells migrate to the lymph nodes to act...
...ch Hospital have discovered that a certain differe...ty that it requires the constant expression of a g...rs showed that Prox1 acts as a two-way switch whos...zed type of cell, called a lymphatic endothelial c... actually loses its identity and assumes character...
...s (the inheritance of propensities acquired in the...und in eggs and other foodsduring pregnancy may si...ther,s offspring. This finding by a team of biolog...line consumption during pregnancy to breast cancer...e-related genetic changes that affect breast cance...
Other Biology News:Immune cells reveal fancy footwork 2Reprogrammable cell type depends on a single gene to keep its identity 2Eating eggs when pregnant affects breast cancer in offspring 2
Virology LabFax from Promega
GIBCO IPL-41 Insect Medium (1X) liquid from Invitrogen
GIBCO Newborn Calf Serum from Invitrogen
BD LSR II System from BD Biosciences - Immunocytometry Systems
Biology Products: